Tokai Pharmaceuticals (TKAI) Priced

Biotech developing small molecule therapies for prostate cancer.

Health Care - Biotechnology

IPO Performance
Latest Trade $0.86 0.00 (0.0%)
First Day Return 58.4%
Return from IPO -94.3%
 
Tokai Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 08/11/2014
Offer Price $15.00
Price Range $13.00 - $15.00
Offer Shares (mm) 6.5
Deal Size ($mm) 97
 
IPO Data
IPO Date 09/17/2014
Offer Price $15.00
Price Range $13.00 - $15.00
Offer Shares (mm) 6.5
Deal Size ($mm) $97
 
Underwriters
more
Business Overview
Biotech developing small molecule therapies for prostate cancer.
Biotech developing small molecule therapies for prostate cancer.
more
Company Data
Headquarters Cambridge, MA
Founded 2004
Employees 17
Website www.tokaipharma.com
 

Performance vs. IPO Index (IPOUSA)